GlassScriptPhysician profile
Mason Uvodich
NPI 1548720519
$37,509.76
in general payments reported to CMS, 2019-2025
7 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $359 · 2021: $572 · 2022: $325 · 2023: $18K · 2024: $6,819 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $29K · Travel and Lodging: $3,101 · Food and Beverage: $2,731 · Education: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $29,285.71 |
| Travel and Lodging | $3,100.81 |
| Food and Beverage | $2,731.08 |
| Education | $655.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $17,782.12 | 2023-2025 | |
| Smith+Nephew, INC. | $14,005.45 | 2024-2025 | Fast-Fix, Novostitch |
| Stryker Corporation | $3,077.84 | 2019-2025 | Mako, Gamma, Aequalis Perform |
| Medical Device Business Services, INC. | $1,970.92 | 2019-2024 | |
| Depuy Synthes Sales INC. | $356.58 | 2020-2023 | Va-Lcp, Tfn-Advance |
| Bodycad USA Corp | $173.35 | 2025 | Fine Osteotomy |
| Lightbody Medical Technologies INC | $143.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Uvodich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.